Literature DB >> 33674578

Engineered yeast genomes accurately assembled from pure and mixed samples.

Joseph H Collins1, Kevin W Keating1, Trent R Jones1, Shravani Balaji1, Celeste B Marsan1, Marina Çomo1, Zachary J Newlon1, Tom Mitchell2, Bryan Bartley2, Aaron Adler2, Nicholas Roehner2, Eric M Young3.   

Abstract

Yeast whole genome sequencing (WGS) lacks end-to-end workflows that identify genetic engineering. Here we present Prymetime, a tool that assembles yeast plasmids and chromosomes and annotates genetic engineering sequences. It is a hybrid workflow-it uses short and long reads as inputs to perform separate linear and circular assembly steps. This structure is necessary to accurately resolve genetic engineering sequences in plasmids and the genome. We show this by assembling diverse engineered yeasts, in some cases revealing unintended deletions and integrations. Furthermore, the resulting whole genomes are high quality, although the underlying assembly software does not consistently resolve highly repetitive genome features. Finally, we assemble plasmids and genome integrations from metagenomic sequencing, even with 1 engineered cell in 1000. This work is a blueprint for building WGS workflows and establishes WGS-based identification of yeast genetic engineering.

Entities:  

Year:  2021        PMID: 33674578     DOI: 10.1038/s41467-021-21656-9

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  88 in total

1.  Microbial engineering for the production of advanced biofuels.

Authors:  Pamela P Peralta-Yahya; Fuzhong Zhang; Stephen B del Cardayre; Jay D Keasling
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

2.  Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications.

Authors:  C B Brachmann; A Davies; G J Cost; E Caputo; J Li; P Hieter; J D Boeke
Journal:  Yeast       Date:  1998-01-30       Impact factor: 3.239

Review 3.  Recent advancements in fungal-derived fuel and chemical production and commercialization.

Authors:  Holly Ekas; Matthew Deaner; Hal S Alper
Journal:  Curr Opin Biotechnol       Date:  2018-09-21       Impact factor: 9.740

Review 4.  Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development.

Authors:  Chris J Paddon; Jay D Keasling
Journal:  Nat Rev Microbiol       Date:  2014-04-01       Impact factor: 60.633

Review 5.  Genetic engineering of host organisms for pharmaceutical synthesis.

Authors:  Joseph H Collins; Eric M Young
Journal:  Curr Opin Biotechnol       Date:  2018-02-19       Impact factor: 9.740

6.  Technological challenges and milestones for writing genomes.

Authors:  Nili Ostrov; Jacob Beal; Tom Ellis; D Benjamin Gordon; Bogumil J Karas; Henry H Lee; Scott C Lenaghan; Jeffery A Schloss; Giovanni Stracquadanio; Axel Trefzer; Joel S Bader; George M Church; Cintia M Coelho; J William Efcavitch; Marc Güell; Leslie A Mitchell; Alec A K Nielsen; Bill Peck; Alexander C Smith; C Neal Stewart; Hille Tekotte
Journal:  Science       Date:  2019-10-18       Impact factor: 47.728

Review 7.  Advances in metabolic engineering of yeast Saccharomyces cerevisiae for production of chemicals.

Authors:  Irina Borodina; Jens Nielsen
Journal:  Biotechnol J       Date:  2014-02-24       Impact factor: 4.677

Review 8.  Production of protein-based polymers in Pichia pastoris.

Authors:  Marc W T Werten; Gerrit Eggink; Martien A Cohen Stuart; Frits A de Wolf
Journal:  Biotechnol Adv       Date:  2019-03-19       Impact factor: 14.227

9.  A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae.

Authors:  R S Sikorski; P Hieter
Journal:  Genetics       Date:  1989-05       Impact factor: 4.562

Review 10.  Organizing genome engineering for the gigabase scale.

Authors:  Bryan A Bartley; Jacob Beal; Jonathan R Karr; Elizabeth A Strychalski
Journal:  Nat Commun       Date:  2020-02-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.